Here are what the editors at HealthDay consider to be the most important developments in Urology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Finasteride Not Tied to Increase in Prostate Cancer Mortality
TUESDAY, Jan. 29, 2019 (HealthDay News) — Finasteride is not associated with an increased risk for death due to prostate cancer, according to a research letter published in the Jan. 24 issue of the New England Journal of Medicine.
Machine Learning Methods Can Detect UTI in Dementia Patients
MONDAY, Jan. 28, 2019 (HealthDay News) — Algorithms that combine Internet of Things (IoT) technologies and in-home sensory devices with machine learning techniques can be used to monitor the health and well-being of people with dementia, according to a study published online Jan. 15 in PLOS ONE.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
Suicide Risk Up More Than Fourfold for Cancer Patients
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Cancer patients have an increased suicide risk, which is predominant among men and white patients, according to a study published online Jan. 14 in Nature Communications.
Personalized Tx May Extend Life in CKD With Small Renal Tumors
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Personalized treatment selection may extend life expectancy in patients with chronic kidney disease (CKD) and small renal tumors (≤4 cm), according to a study published online Jan. 15 in Radiology.
Study Explores Influence of Genetics, Environment in Disease